Try our Advanced Search for more refined results

BURLINGTON DRUG CO., INC. et al v. PFIZER INC. et al

  1. November 19, 2012

    Pfizer Says Lipitor Buyers Can't Bring Antitrust Challenge

    Pfizer Inc. sought Friday to end a class action concerning its purportedly anti-competitive settlement resolving patent litigation over Ranbaxy Inc.'s generic challenge to Pfizer's cholesterol drug Lipitor, telling a New Jersey federal court that the drug retailer plaintiffs lack standing to pursue the case.

  2. October 25, 2012

    Pfizer, Ranbaxy Can't Pause Lipitor Pay-For-Delay Suit

    A New Jersey judge has refused to halt multidistrict antitrust litigation challenging patent infringement settlements Pfizer Inc. reached over its cholesterol treatment Lipitor, ruling that waiting for the U.S. Supreme Court to take and decide similar suits over pay-for-delay deals would stall the case too long.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!